Home/Matinas Biopharma/Robin L. Smith

RL

Robin L. Smith

Board Member

Matinas Biopharma

Therapeutic Areas

Infectious Disease Inflammation Oncology

Matinas Biopharma Pipeline

Drug	Indication	Phase
MAT2203	Invasive Fungal Infections (Candidiasis, Aspergillosis)	Phase 2/3
LNC Platform Discovery	Oncology & Inflammation	Discovery

Leadership Team at Matinas Biopharma

Jerome D. Jabbour

Chief Executive Officer

Board Member, Chair of Nominating and Governance Committee

Edward Neugeboren

Board Member, Chair of Compensation Committee

Board Member, Audit Committee Chair

View full Matinas Biopharma profile